£1.6m raised by lab test developer Fuse Diagnostics
Fuse Diagnostics has announced that it has completed an oversubscribed seed investment round.
Stay updated with breaking news from Ralph Lamble. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fuse Diagnostics has announced that it has completed an oversubscribed seed investment round.
Published: Feb 18, 2021 Senior Executives Appointed to Lead Commercialization of Sense’s Products to Deliver Patient-Focused, Decentralized Healthcare Sense Biodetection (Sense), a leading innovator in the emerging field of instrument-free molecular diagnostics, has announced the appointment of Simon Turner as Chief Financial Officer and Ryan Roberts as Chief Commercial Officer. The Company has also established a new distribution center in Boston, MA as it readies for U.S. and global launch of its first product, the Veros™ COVID-19 test. Turner, a veteran international finance and ope...